The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| WATCHMAN FLX™ CT Study (NCT05324371) | Boston Scientific Corporation | 2022-11-09 |
Track The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation automatically
Every clearance here is in the API, with alerts when new ones post.